Hospitals could be without tocilizumab, one of the only therapies for Covid-19 patients cleared for use in the U.S., for weeks and the World Health Organization urged maker Roche to ensure it is distributed fairly around the world.
U.S. Hospitals Are Running Out Of A Crucial Covid Drug Amid Delta Surge And Worldwide Shortages
